Abdul W. Ansari
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axis.
Journal: Toxicology and applied pharmacology
Published: February 05, 2026
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axis.
Journal: Toxicology and applied pharmacology
Published: February 05, 2026
Longitudinal Plasma Proteome of Pfizer/BNT162b2 Pre- and Postbooster Vaccinated Healthy Individuals Reveals Distinct Protein Profiles upon SARS-CoV-2 Spike Protein Stimulation.
Journal: Journal of proteome research
Published: February 03, 2026
Protein misfolding and unfolded protein response in cancer: Current updates with focus on epigenetic regulation.
Journal: Advances in protein chemistry and structural biology
Published: November 27, 2025
Protein misfolding and cancer - proteomics as an approach for biomarker discovery.
Journal: Advances in protein chemistry and structural biology
Published: November 27, 2025
Selective induction of apoptosis in T-cell acute lymphoblastic leukemia by pristimerin through dual PI3K/AKT pathway inhibition and ROS generation.
Journal: European journal of pharmacology
Published: June 25, 2025
Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1/STAT1 Pathway.
Journal: The Journal of investigative dermatology
Published: June 11, 2025
Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma.
Journal: International review of cell and molecular biology
Published: February 12, 2025
The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition.
Journal: Cell proliferation
Published: August 11, 2024
Virus-Induced Host Chemokine CCL2 in COVID-19 Pathogenesis: Potential Prognostic Marker and Target of Anti-Inflammatory Strategy.
Journal: Reviews in medical virology
Published: June 19, 2024
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
Journal: Frontiers in immunology
Published: June 11, 2024
Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 22, 2024
Last Updated: 09/26/2026